Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 0 % of short-term debt in 2025; threshold 65 %.
-
Legal situation KBO
Vrijwillige ontbinding – vereffening according to the CBE.
Financials
Financial year 2025
Matrix Laboratories from Hoeilaart, company number BE0874864378, closed financial year 2025 with a result of € -27,627 after tax. Compared with financial year 2024, the result moved from € -32,070 to € -27,627. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 7, 2026.
€ -16.2 million
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -27,627
▲ 14 % less loss than in 2024
Profit after tax over the fiscal year.
Loss, nothing to pay out
Reserves fell to € -157.2 million.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 13,685
▲ 3% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 355 days on average.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Profit after taxes | € -15,772 | € -27,735 | € -32,070 | € -27,627 | ▲ € 4,444 |
| Equity | € -16,109,940 | € -16,137,675 | € -16,169,746 | € -16,197,372 | |
| Total debts | € 16,109,955 | € 16,137,689 | € 16,169,760 | € 16,197,387 | |
| Retained profit | € -157,142,964 | € -157,170,699 | € -157,202,769 | € -157,230,396 | |
| Balance sheet total | € 14 | € 14 | € 14 | € 14 |
Key figures of Matrix Laboratories, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Matrix Laboratories?
What happened at Matrix Laboratories in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
Matrix Laboratories is active according to the CBE. Legal situation: Vrijwillige ontbinding – vereffening.
- New annual accounts for financial year 2025: loss of € 27,627. Source: NBB ↗
- Vincent VERSCHRAEGEN became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 15,772 loss in 2022 to € 27,627 loss in 2025.
A new publication or filing at Matrix Laboratories? We notify you, reason included.
Follow Matrix LaboratoriesDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Matrix Laboratories is Vincent VERSCHRAEGEN. The shares are held by Mylan Luxembourg 2 Sarl (60%) and Mylan Luxembourg 6 Sarl (40%). It owns 0% of AKTUAPHARMA itself.
Directors
According to the 2025 annual accounts
Vincent VERSCHRAEGEN
Liquidator
Also active at: AKTUAPHARMA, DOCPHARMA, FeBelGen, Viatris, Viatris GX
since 2018
Shareholders
Mylan Luxembourg 2 Sarl
60%
Mylan Luxembourg 6 Sarl
40%
Participations
0%
Establishments
Establishment units
Physical locations of this company
Terhulpsesteenweg 6 box A
1560 Hoeilaart
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0874.864.378
- VAT number
- BE 0874.864.378
- Registered office
- Terhulpsesteenweg 6 bus A, 1560 Hoeilaart
- Names & denominations
- Matrix Laboratories
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Vrijwillige ontbinding – vereffening
- Start date
- 29 June 2005
- Peppol
- Active · Active since 16 Dec 2025